Literature DB >> 15625650

Suicidal ideation in patients with irritable bowel syndrome.

Vivien Miller1, Louise Hopkins, Peter J Whorwell.   

Abstract

BACKGROUND & AIMS: Irritable bowel syndrome (IBS) traditionally is considered as more of a nuisance than having especially serious consequences. However, this is not the picture witnessed in tertiary care where we have encountered some tragic cases, prompting an assessment of suicidal ideation in such patients.
METHODS: One hundred follow-up, tertiary care IBS (tIBS) patients were compared with 100 secondary IBS (sIBS), 100 primary IBS (pIBS) care patients, and 100 patients with active inflammatory bowel disease (IBD). Patients were asked if they had either seriously contemplated or attempted suicide specifically because of their bowel problem as opposed to other issues. The hospital anxiety depression score was recorded, as were other clinical details on all patients.
RESULTS: A total of 38% of tIBS patients had contemplated suicide because of their symptoms compared with 16% and 4% in the sIBS and pIBS groups (tIBS vs. sIBS vs. pIBS, P = .002, P < .001). The figure for IBD was 15% (tIBS v. IBD, P < .001). Five tIBS and 1 IBD patient had attempted suicide for gastrointestinal reasons. Mean depression scores did not exceed threshold (10) in the sIBS group contemplating suicide (9.7), but were increased in the equivalent tIBS group (11.7). Hopelessness because of symptom severity, interference with life, and inadequacy of treatment were highlighted as crucial issues for all IBS patients.
CONCLUSIONS: IBS has the potential for a fatal outcome from suicide with depression not accounting for all the variance in suicidal ideation. Our observations emphasize the level of hopelessness felt by these patients and the need for improvement in the services provided to them.

Entities:  

Mesh:

Year:  2004        PMID: 15625650     DOI: 10.1016/s1542-3565(04)00545-2

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  30 in total

1.  The challenge of developing new therapies for irritable bowel syndrome.

Authors:  Fernando Azpiroz; Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome.

Authors:  Susan L Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

Review 3.  Irritable bowel syndrome: diagnosis and management.

Authors:  A Agrawal; P J Whorwell
Journal:  BMJ       Date:  2006-02-04

4.  Behavioral therapy for IBS.

Authors:  Peter J Whorwell
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-02-03

Review 5.  New treatments for IBS.

Authors:  Magnus Halland; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-13       Impact factor: 46.802

6.  [A Meta-Analysis on the Effects of Mind-Body Therapy on Patients with Irritable Bowel Syndrome].

Authors:  Eun Hui Choi; Moon Ja Kim; Eun Nam Lee
Journal:  J Korean Acad Nurs       Date:  2020-06       Impact factor: 0.984

7.  Q&A: Peter Whorwell.

Authors:  Helen Pilcher
Journal:  Nature       Date:  2016-05-19       Impact factor: 49.962

8.  Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis/bladder pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Adrijana Krsmanovic; Michel Pontari; Robert Moldwin; Robert Mayer; Lesley K Carr; Claire C Yang; Jorgen Nordling
Journal:  Can Urol Assoc J       Date:  2016 Nov-Dec       Impact factor: 1.862

Review 9.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

Review 10.  The burden of IBS: looking at metrics.

Authors:  Brennan M R Spiegel
Journal:  Curr Gastroenterol Rep       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.